IMMX vs. VMNIX

In the year-to-date period, IMMX achieves a -5.00% return, which is significantly lower than VMNIX's 1.56% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Immix Biopharma, Inc. (IMMX) and Vanguard Market Neutral Fund Institutional Shares (VMNIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current IMMX Sharpe Ratio is -0.05, which is lower than the VMNIX Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of IMMX and VMNIX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

IMMX has not paid dividends to shareholders, while VMNIX's dividend yield for the trailing twelve months is around 5.65%.

The maximum IMMX drawdown since its inception was -88.89%, which is greater than VMNIX's maximum drawdown of -25.35%. Use the drawdown chart below to compare losses from any high point for IMMX and VMNIX. For additional features, visit the drawdowns tool.

Immix Biopharma, Inc. (IMMX) has a higher volatility of 19.64% compared to Vanguard Market Neutral Fund Institutional Shares (VMNIX) at 1.60%. This indicates that IMMX's price experiences larger fluctuations and is considered to be riskier than VMNIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.